{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:23:32Z","timestamp":1781115812976,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Neisseria gonorrhoeae<\/jats:italic> bacteria are acknowledged as an urgent threat to human health because this species has developed resistances to all of the antibiotics used clinically to treat its infections. <jats:italic>N. gonorrhoeae<\/jats:italic> causes the sexually transmitted disease gonorrhoea, but also causes blindness when the bacteria infect the eyes. Infants are particularly susceptible, acquiring the infection from their mothers at birth. We have shown that the monoglyceride monocaprin rapidly kills <jats:italic>N. gonorrhoeae<\/jats:italic> and other bacterial species and is non-irritating in ocular assays. Here we show that the physical and chemical properties of monocaprin make it ideal for use in a thickened eye drop formulation to combat eye infections. Monocaprin-containing formulations were assessed using analytical techniques and for antimicrobial activity in vitro and in ex vivo infections. Monocaprin-containing formulations retained activity after three years and are non-irritating, unlike preparations of povidone iodine in our assays. A recommended formulation for further development and investigation is 0.25% monocaprin in 1% HPMC with 1% polysorbate 20.<\/jats:p>","DOI":"10.1038\/s41598-020-68722-8","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:02:52Z","timestamp":1595325772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Monocaprin eye drop formulation to combat antibiotic resistant gonococcal blindness"],"prefix":"10.1038","volume":"10","author":[{"given":"Colin P.","family":"Churchward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Al-Kinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"Abdelkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Swinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opeoluwa","family":"Siwoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinuba","family":"Varnakulasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raid G.","family":"Alany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A. S.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"68722_CR1","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/mBio.00534-17","volume":"8","author":"CP Churchward","year":"2017","unstructured":"Churchward, C. P., Alany, R. G., Kirk, R. S., Walker, A. J. & Snyder, L. A. S. Prevention of ophthalmia neonatorum caused by Neisseria gonorrhoeae using a fatty acid-based formulation. MBio 8, e00534-e617 (2017).","journal-title":"MBio"},{"key":"68722_CR2","doi-asserted-by":"publisher","first-page":"e0195453","DOI":"10.1371\/journal.pone.0195453","volume":"13","author":"CP Churchward","year":"2018","unstructured":"Churchward, C. P., Calder, A. & Snyder, L. A. S. Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance. PLoS ONE 13, e0195453 (2018).","journal-title":"PLoS ONE"},{"key":"68722_CR3","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.3390\/antibiotics7030059","volume":"7","author":"V Dolange","year":"2018","unstructured":"Dolange, V., Churchward, C. P., Christodoulides, M. & Snyder, L. A. S. The growing threat of gonococcal blindness. Antibiotics 7, E59 (2018).","journal-title":"Antibiotics"},{"key":"68722_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10792-014-0032-8","volume":"35","author":"E McElnea","year":"2015","unstructured":"McElnea, E., Stapleton, P., Khan, S., Stokes, J. & Higgins, G. Challenges in the management of Neisseria gonorrhoeae keratitis. Int. Ophthalmol. 35, 135\u2013140 (2015).","journal-title":"Int. Ophthalmol."},{"key":"68722_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/eye.2015.57","volume":"29","author":"L McAnena","year":"2015","unstructured":"McAnena, L., Knowles, S. J., Curry, A. & Cassidy, L. Prevalence of gonococcal conjunctivitis in adults and neonates. Eye 29, 875\u2013880 (2015).","journal-title":"Eye"},{"key":"68722_CR6","doi-asserted-by":"publisher","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","volume":"23","author":"DW Eyre","year":"2018","unstructured":"Eyre, D. W. et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eurosurveillance 23, 1800323 (2018).","journal-title":"Eurosurveillance"},{"key":"68722_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.56.3.368","volume":"56","author":"H Nishida","year":"1975","unstructured":"Nishida, H. & Risemberg, H. M. Silver nitrate ophthalmic solution and chemical conjunctivities. Pediatrics 56, 368\u2013373 (1975).","journal-title":"Pediatrics"},{"key":"68722_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/tropej\/fmm049","volume":"53","author":"Z Ali","year":"2007","unstructured":"Ali, Z. et al. Prophylaxis of ophthalmia neonatorum comparison of betadine, erythromycin and no prophylaxis. J. Trop. Pediatr. 53, 388\u2013392 (2007).","journal-title":"J. Trop. Pediatr."},{"key":"68722_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo, M. & Shafer, W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin. Microbiol. Rev. 27, 587\u2013613 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"68722_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski, K. A. & Bolan, G. A. CDC Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommun. Rep. 64, 1\u2013140 (2015).","journal-title":"MMWR Recommun. Rep."},{"key":"68722_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJM199503023320903","volume":"332","author":"SJ Isenberg","year":"1995","unstructured":"Isenberg, S. J., Apt, L. & Wood, M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N. Engl. J. Med. 332, 562\u2013566 (1995).","journal-title":"N. Engl. J. Med."},{"key":"68722_CR12","unstructured":"WHO guidelines for the treatment of Neisseria gonorrhoeae. https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/gonorrhoea-treatment-guidelines\/en\/ (2016)."},{"key":"68722_CR13","unstructured":"Fifer, H. Saunders, J., Soni, S., Sadiq, S. T. & FitzGerald, M. British Association for Sexual Health and HIV guidelines for the management of infection with Neisseria gonorrhoeae. www.bashhguidelines.org\/media\/1208\/gc-2019.pdf (2019)."},{"key":"68722_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0002-9394(89)90495-9","volume":"107","author":"R Haimovici","year":"1989","unstructured":"Haimovici, R. & Rousseil, T. J. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am. J. Ophthalmol. 107, 511\u2013514 (1989).","journal-title":"Am. J. Ophthalmol."},{"key":"68722_CR15","first-page":"471","volume":"67","author":"M Laga","year":"1989","unstructured":"Laga, M., Meheus, A. & Piot, P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull. World Health Organ. 67, 471 (1989).","journal-title":"Bull. World Health Organ."},{"key":"68722_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/sti.75.3.181","volume":"75","author":"H Thormar","year":"1999","unstructured":"Thormar, H. et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex. Transm. Infect. 75, 181\u2013185 (1999).","journal-title":"Sex. Transm. Infect."},{"key":"68722_CR17","unstructured":"Davies, J.T. A quantitative kinetic theory of emulsion type. I. Physical chemistry of the emulsifying agent. Gas\/liquid and liquid\/liquid interfaces. In: Proceedings of 2nd International Congress Surface Activity: 1957 426\u2013438 (Butterworths, London, 1957)."},{"key":"68722_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jchromb.2013.05.026","volume":"932","author":"BS Chu","year":"2013","unstructured":"Chu, B. S. & Nagy, K. Enrichment and quantification of monoacylglycerols and free fatty acids by solid phase extraction and liquid chromatography\u2013mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 932, 50\u201358 (2013).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"68722_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0039-6257(78)90178-9","volume":"22","author":"JS Robin","year":"1978","unstructured":"Robin, J. S. & Ellis, P. P. Ophthalmic ointments. Surv. Ophthalmol. 22, 335\u2013340 (1978).","journal-title":"Surv. Ophthalmol."},{"key":"68722_CR20","volume-title":"Pharmaceutics: The Science of Dosage Form Design","author":"ME Aulton","year":"2002","unstructured":"Aulton, M. E. Pharmaceutics: The Science of Dosage Form Design (Churchill Livingstone, London, 2002)."},{"key":"68722_CR21","unstructured":"Food Standards Agency, UK. Current EU approved additives and their E Numbers. https:\/\/www.food.gov.uk\/science\/additives\/enumberlist (2016)."},{"key":"68722_CR22","first-page":"286","volume":"58","author":"TO Thorgeirsdottir","year":"2003","unstructured":"Thorgeirsdottir, T. O., Thormar, H. & Kristmundsdottir, T. Effects of polysorbates on antiviral and antibacterial activity of monoglyceride in pharmaceutical formulations. Pharmazie 58, 286\u2013287 (2003).","journal-title":"Pharmazie"},{"key":"68722_CR23","unstructured":"Guideline ICH. Validation of analytical procedures: text and methodology. Q2 (R1). https:\/\/database.ich.org\/sites\/default\/files\/Q2_R1__Guideline.pdf (2005)."},{"issue":"10","key":"68722_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/js9900396","volume":"88","author":"T Kristmundsd\u00f3ttir","year":"1999","unstructured":"Kristmundsd\u00f3ttir, T., Arnad\u00f3ttir, S. G., Bergsson, G. & Thormar, H. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient. J. Pharm. Sci. 88(10), 1011\u20131015 (1999).","journal-title":"J. Pharm. Sci."},{"key":"68722_CR25","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00705-007-1063-5","volume":"152","author":"H Hilmarsson","year":"2007","unstructured":"Hilmarsson, H., Traustason, B. S., Kristmundsd\u00f3ttir, T. & Thormar, H. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels. Arch. Virol. 152, 2225\u20132236 (2007).","journal-title":"Arch. Virol."},{"issue":"20","key":"68722_CR26","first-page":"30292","volume":"S0188\u20134409","author":"UN Das","year":"2020","unstructured":"Das, U. N. Can bioactive lipids inactivate coronavirus (COVID-19)?. Arch. Med. Res. S0188\u20134409(20), 30292\u201330297 (2020).","journal-title":"Arch. Med. Res."},{"key":"68722_CR27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/JB.85.6.1274-1279.1963","volume":"85","author":"DS Kellogg Jr","year":"1963","unstructured":"Kellogg, D. S. Jr., Peacock, W. L. Jr., Deacon, W. E., Brown, L. & Pirkle, D. I. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85, 1274\u20131279 (1963).","journal-title":"J. Bacteriol."},{"key":"68722_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000366228","volume":"53","author":"O Alekseev","year":"2014","unstructured":"Alekseev, O., Limonnik, V., Donovan, K. & Azizkhan-Clifford, J. Activation of checkpoint kinase 2 is critical for Herpes Simplex Virus Type 1 replication in corneal epithelium. Ophthalmic Res. 53, 55\u201364 (2014).","journal-title":"Ophthalmic Res."},{"key":"68722_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1167\/iovs.13-13461","volume":"55","author":"O Alekseev","year":"2014","unstructured":"Alekseev, O., Donovan, K. & Azizkhan-Clifford, J. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis. Invest. Ophthalmol. Vis. Sci. 55, 706\u2013715 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"68722_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0887-2333(90)90061-W","volume":"4","author":"YHM van Erp","year":"1990","unstructured":"van Erp, Y. H. M. & Weterings, P. J. J. M. Eye irritancy screening for classification of chemicals. Toxicol. In Vitro 4, 267\u2013269 (1990).","journal-title":"Toxicol. In Vitro"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68722-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68722-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68722-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:59:27Z","timestamp":1670335167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68722-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68722"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68722-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Raid G. Alany and Lori A. S. Snyder are co-inventor of UK patent GB1701450.7 (pending)\/EU patent 18154222.6-1112 (pending). The rest of the authors declare to have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12010"}}